Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Jayamas Medica Industri Tbk's quarterly finished goods
declined
from Dec. 2025 (Rp499,847 Mil) to Mar. 2026 (Rp454,005 Mil) but then
increased
from Mar. 2026 (Rp454,005 Mil) to Jun. 2026 (Rp474,253 Mil).
PT Jayamas Medica Industri Tbk's annual finished goods
increased
from Dec. 2023 (Rp353,630 Mil) to Dec. 2024 (Rp399,593 Mil) and
increased
from Dec. 2024 (Rp399,593 Mil) to Dec. 2025 (Rp499,847 Mil).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Jayamas Medica Industri Tbk Inventories, Finished Goods Chart
What does a Inventories, Finished Goods of Rp474,253 Mil mean?
PT Jayamas Medica Industri Tbk (ISX:OMED) has a Inventories, Finished Goods of Rp474,253 Mil as of Jun. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on PT Jayamas Medica Industri Tbk and its competitors.
Is PT Jayamas Medica Industri Tbk's Inventories, Finished Goods too high?
PT Jayamas Medica Industri Tbk's current Inventories, Finished Goods is Rp474,253 Mil. Overall, PT Jayamas Medica Industri Tbk has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PT Jayamas Medica Industri Tbk's Inventories, Finished Goods compare to ISRG and BDX?
PT Jayamas Medica Industri Tbk's Inventories, Finished Goods of Rp474,253 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Medical Devices & Instruments company?
A good Inventories, Finished Goods depends on the Medical Devices & Instruments industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on PT Jayamas Medica Industri Tbk and its competitors. PT Jayamas Medica Industri Tbk's current Inventories, Finished Goods is Rp474,253 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Jayamas Medica Industri Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Jayamas Medica Industri Tbk (ISX:OMED) is currently considered Fairly Valued. The stock's GF Value™ is Rp239.45, compared to a current price of Rp228.00 — trading 4.8% below its estimated fair value. The current Inventories, Finished Goods is Rp474,253 Mil. PT Jayamas Medica Industri Tbk's overall GF Score™ is 89/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For PT Jayamas Medica Industri Tbk (ISX:OMED), the current Inventories, Finished Goods is Rp474,253 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Jayamas Medica Industri Tbk (ISX:OMED) Overvalued in 2026?
Based on GuruFocus' analysis, PT Jayamas Medica Industri Tbk stock appears to be undervalued.
The current stock price of Rp228.00 is trading 4.8% below its estimated GF Value™ of Rp239.45.
GuruFocus considers PT Jayamas Medica Industri Tbk to be Fairly Valued.
Key valuation signals for ISX:OMED:
Inventories, Finished Goods: Rp474,253 Mil
GF Value™: Rp239.45 vs. price of Rp228.00 (4.8% below fair value)
No single metric tells the full story. See the ISX:OMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Jayamas Medica Industri Tbk is engaged in the business of manufacturing, wholesale and retail trade of medical devices. Its offerings include Disposable and Expendable Medical Supplies, Wound Care, Diagnostics and Equipment, Antiseptics and Dialysis, Biotechnology and Laboratory, Ambulatory and Rehabilitation Care The company has three segments: i) Manufacturing: This division is involved in the manufacturing of medical supplies and equipment, ii) Distribution: This division is involved with the large scale distribution of medical supplies and equipment at strategic locations, iii) Retail: This division is involved with the retail of medical supplies and equipment through Medicom stores and online platforms. The majority of the company's revenue is derived from the Distribution segment.
89GF Score
Get the complete analysis for ISX:OMED
Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:OMED has been successfully added to your 
